Merith Basey Named Executive Director Of Patients For Affordable Drugs
Basey Has Devoted Her Career To Ensuring That Life-saving Medications Are Affordable And Accessible For All Who Need Them
JULY PRICE HIKES REPORT: Big Pharma’s Continued Greed Underscores Urgent Need For Reform To Lower Drug Prices
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
July 2022 Price Hikes Report
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
NEW REPORT: Big Pharma’s Lockstep Price Hikes On Widely Used Blood Thinners Exploit Patients And Taxpayers
A new report issued today documents how drug companies use their market and political power to avoid competition and raise prices in lockstep.
JANUARY PRICE HIKES 2.0: Big Pharma Pushes Blockbuster Prices To New Heights
Since P4AD’s initial report in mid-January, drug companies have increased the price of 188 more drugs, bringing the total to 742 hikes so far this year.
Round 2 Of January 2022 Hikes Pushes Blockbuster Prices To New Heights
Drug companies raised the prices of 742 drugs in January 2022
January Price Hikes 2.0 Methodology and Data Set
Methodology and Dataset for January Price Hikes 2.0 Report
JANUARY 2022 PRICE HIKES REPORT: A New Year Brings The Same Old Bad Behavior By Big Pharma
The report demonstrates why urgent congressional action is needed to address Big Pharma’s abusive pricing practices.
